REQUEST A DEMO
Total
USD $0.00
Search more companies

Super Formulations Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Super Formulations Private Limited Profile Updated: January 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Super Formulations Private Limited is an unlisted company, incorporated on 26/07/2004. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP2004PTC016782 and registration number is 016782. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Headquarters
16B 16D &15F Industrial Area Maxi Road Ujjain In-Mp In 456010
Ujjain; Madhya Pradesh; Postal Code: 456010

Contact Details: Purchase the Super Formulations Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Super Formulations Private Limited report to view the information.
Outstanding Shares:
Purchase the Super Formulations Private Limited report to view the information.
Registered Capital:
Purchase the Super Formulations Private Limited report to view the information.
Incorporation Date:
July 26, 2004
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
24.41%
Company Performance
Financial values in the chart are available after Super Formulations Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
32.08%
Total operating revenue
32.51%
Operating profit (EBIT)
116.5%
EBITDA
84.18%
Net Profit (Loss) for the Period
118.19%
Total assets
25%
Total equity
48.63%
Operating Profit Margin (ROS)
1.12%
Net Profit Margin
0.83%
Return on Equity (ROE)
10.43%
Debt to Equity Ratio
-73.1%
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?